IVF Group Surrogacy Services is genuinely proud that the embryological laboratory of the Network of Reproductive Centers "Mother and Child" is capable of exercising the next generation sequencing (NGS) method in reproductive medicine that has greatly validated the credibility of pre-implantation genetic diagnosis (PGD). Specifically, for the aforesaid purposes the laboratory has acquired a genetic analyzer and NGS sequencer.
The NGS method helps to conduct genetic analysis at the stage of fetal development using specialized panels for the screening of gene mutations in the diagnosis of hereditary diseases such as cystic fibrosis, phenylketonuria, Martin-Bell syndrome, spinal muscular atrophy, neurosensory non-syndromic tiredness, and others.
Our laboratory performs Polymerase Chain Reaction (PCR) by isolating the DNA, preparing the required mixture of primers and probes that will complement the chromosome.
Currently, our lab scientists are exploring the potential of the revolutionary CRISPR technology (Clustetred Regularly Interspaced Short Palindromic Repeats), which is expected to allow editing a damaged genome. We are looking forward to positive results in this field. In the meantime, all our patients will be able to complete a genetic study of a future child in one of the best specialized laboratories in Ukraine. The laboratory of the Network of Reproductive Centers "Mother and Child" has been certified by the Ministry of Health of Ukraine and soon will be undergoing the certification at the International Organization for Standardization.
IVF Group Surrogacy Services is a reliable link between our laboratory qualified staff and our clients and patients.
IVF Group Surrogacy Services through the Network of Reproductive Centers "Mother and Child" is pleased to present you with a unique way of conducting a genetic analysis by decoding DNA and further interpretation of its results.
The genetic material is taken from the cells and subsequently the selected material is sequenced by using chemical reactions and analyzers. Our qualified medical staff determines in which sequence the monomers are located within the genetic code.
Running a sequencer, a device that decrypts a DNA sequence is an extremely cumbersome and cost-consuming process. Therefore, you should contact a laboratory with an excellent reputation that is possession of both competent specialists and a proven track of trustworthy outcomes.
IVF Group Surrogacy Services is assured that medical specialists at the Network of Reproductive Centers "Mother and Child" have achieved startling results in genetic analysis and have demonstrated the scientific effectiveness of their progressive methods and innovative approaches.
When people decide to have a child, a genetic test is a must. In order to prevent genetic diseases, the doctors of our Centers "Mother and Child" advise people who have a history of various multifactorial hereditary diseases that are also called "polygenic with a threshold effect", such as different types of cancer, diabetes and coronary heart disease to undergo a genetic test analysis.
IVF Group Surrogacy Services is perfectly aware that planning to have children is an important step in the life of any person. Medical staff at "Mother and Child" Reproductive Centers advises potential parents to undergo a genetic test that will help determine whether the child will inherit dormant mutations and the risks of congenital abnormalities. This is important when there are frequent cases of some diseases in the family history.
How it works. In essence, such tests are no different from identifying susceptibility to disease in adults, but simultaneously analyze two parental genomes.
What is important to consider. The complexity of the analysis lies in the fact that it is impossible to find out in advance exactly which genes of the parents will be passed on to the child. This is kind of a lottery. Genes always work in a complex way, which makes the number of variations in the genome of the unborn child endless. That is, the test for heredity of the planned offspring is always probabilistic, and even the presence of “bad” mutations in the parents does not make the birth of a healthy child impossible.
Prenatal diagnosis is one of the most important stages in pregnancy planning. Genetic analysis is performed during the pregnancy period and is needed if you suspect congenital abnormalities. Also, prenatal genetic diagnosis can determine the sex of an unborn child at an early stage of pregnancy and establish paternity.
For prenatal diagnosis, there are several methods for taking a sample of genetic material, the most important of which are chorionic biopsy (taking a piece of embryo tissue) and amniocentesis (taking a sample of amniotic fluid). Recently, a non-invasive prenatal DNA test (NIPT) has been widely practicing by our medical specialists through the isolation of the embryo's DNA from the mother's blood. During in vitro fertilization, preimplantation diagnosis is also possible. DNA is isolated from the embryo cell prior to its introduction into the uterus.
Invasive methods are always a risk. Thus, the probability of spontaneous abortion after a biopsy reaches 15%, and amniocentesis can lead to infection or detachment of the membranes of the fetus. Both of these methods become possible at a relatively late gestational age, when a fetal bladder and an embryo clearly visible during the ultrasound procedure. They are used when there are serious suspicions of gene or chromosomal defects. Non-invasive diagnostics has no such consequences, and they can be performed starting from the ninth week of pregnancy.
IVF Group Surrogacy Services and the Network of Reproductive Centers "Mother and Child" are proud to be affiliated with the one the leading genetic laboratories in Ukraine that has modern medical equipment and a highly professional team of specialists. In addition to diagnostics, our genetic laboratory specializes in research, development and production of biotechnological solutions.